A detailed history of Charles Schwab Investment Management Inc transactions in Citius Pharmaceuticals, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 76,073 shares of CTXR stock, worth $238,108. This represents 0.0% of its overall portfolio holdings.

Number of Shares
76,073
Previous 76,073 -0.0%
Holding current value
$238,108
Previous $44,000 13.64%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

SELL
$0.58 - $1.03 $162,934 - $289,348
-280,921 Reduced 78.69%
76,073 $44,000
Q2 2023

Aug 09, 2023

BUY
$1.08 - $1.65 $303,394 - $463,519
280,921 Added 369.28%
356,994 $428,000
Q2 2022

Aug 15, 2022

SELL
$0.88 - $1.87 $243,563 - $517,572
-276,777 Reduced 78.44%
76,073 $70,000
Q1 2022

May 13, 2022

BUY
$1.38 - $1.89 $95,306 - $130,529
69,063 Added 24.34%
352,850 $632,000
Q2 2021

Aug 16, 2021

BUY
$1.51 - $4.23 $363,543 - $1.02 Million
240,757 Added 559.51%
283,787 $988,000
Q1 2021

May 17, 2021

BUY
$1.04 - $2.34 $44,751 - $100,690
43,030 New
43,030 $77,000

Others Institutions Holding CTXR

About Citius Pharmaceuticals, Inc.


  • Ticker CTXR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 146,130,000
  • Market Cap $457M
  • Description
  • Citius Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and commercialization of critical care products focusing on anti-infective products in adjunct cancer care, prescription products, and mesenchymal stem cell therapy. The company is developing five proprietary products comprising Mino-Lok, an antibiotic l...
More about CTXR
Track This Portfolio

Track Charles Schwab Investment Management Inc Portfolio

Follow Charles Schwab Investment Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.